Diagnostic Imaging Staff

Articles by Diagnostic Imaging Staff

University of Pennsylvania researchers have developed an experimental MRI contrast agent capable of targeting tumors, according to a report in the journal ACS Nano. Its coating, instead of targeting particular cancer receptors - which can be hit-or-miss and depend on the cancer - is attracted to the acidic environments in which tumors generally thrive.

While 71 percent of healthcare organizations are either using or considering the deployment of cloud computing or storage technologies, trust in public-cloud services such as those offered by Amazon, Google and others remains weak, according to a new KLAS report. PACS is an area of particular interest in terms of leveraging the cloud, according to the report.

CHICAGO - Breast-Specific Gamma Imaging (BSGI) has greater sensitivity and comparable specificity compared to mammography and ultrasound, according to a new study presented Tuesday at RSNA. A second study presented Tuesday showed that, unlike mammography, BSGI is as effective in detecting breast cancer in women with dense and non-dense breasts.

Inhaling undiluted, hyperpolarized xenon 129 for magnetic resonance imaging of the lungs is safe for chronic obstructive pulmonary disease (COPD) patients as well as healthy volunteers, Duke University researchers reported online on Nov. 4 in the journal Radiology.

The U.S. Food and Drug Administration (FDA) has cleared GE Healthcare’s SenoBright contrast enhanced spectral mammography (CESM) unit, the company announced on Thursday. The technology is designed to produce contrast-enhanced images of the breast using an x-ray contrast agent and a dual energy acquisition technique.

Toshiba American Systems Inc. today announced FDA clearance of their M-Power interface aimed at increasing MR exam efficiency. The customizable user interface enables technologists to streamline and accelerate the imaging process and enhance diagnosis, according to the company.